<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Tele-Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjXyDQPk8S6VBAOJtdGAAAAAg","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Tele-Glaucoma","wgTitle":"Tele-Glaucoma","wgCurRevisionId":83950,"wgRevisionId":83950,"wgArticleId":6645,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Tele-Glaucoma","wgRelevantArticleId":6645,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":
"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Glaucoma is a progressive optic neuropathy with characteristic optic nerve structural damage and visual field loss. Glaucoma is one of the common causes of irreversible blindness worldwide.1&amp;#91;1&amp;#93; While there are many types of glaucoma including open-angle, closed-angle, and normal tension glaucoma; primary open-angle glaucoma is the most frequent encountered in the  US 2,3.&amp;#91;2&amp;#93;&amp;#91;3&amp;#93; Primary open angle glaucoma is often labeled as the “silent thief of vision” due its characteristic painless and slow progression of mostly peripheral vision loss1. There are many barriers that prevent patients from seeking appropriate eye care including, but not limited to, geographic, educational, socioeconomic, and cultural considerations. 2,3&amp;#91;2&amp;#93;&amp;#91;3&amp;#93;"/>
<meta name="date" content="2022-08-14"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Tele-Glaucoma" href="/w/index.php?title=Special:ExportRDF/Tele-Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Tele-Glaucoma rootpage-Tele-Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Tele-Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Tele-Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzz03erg"></button>
					<div class="collapse navbar-collapse hbpzz03erg" id="hbpzz03erg">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Tele-Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk"><a href="/Talk:Tele-Glaucoma" rel="discussion" title="Discussion about the content page [t]" accesskey="t" class="ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Tele-Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Tele-Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Tele-Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Tele-Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Tele-Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Albertkhouri" title="User:Albertkhouri">Albert S Khouri, MD</a>,&#8201;<a href="/w/index.php?title=User:Ashley_Ooms&amp;action=formedit&amp;redlink=1" class="new" title="User:Ashley Ooms (page does not exist)">Ashley Ooms</a>,&#8201;<a href="/w/index.php?title=User:Ben_Szirth_PhD&amp;action=formedit&amp;redlink=1" class="new" title="User:Ben Szirth PhD (page does not exist)">Ben Szirth PhD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Albertkhouri" title="User:Albertkhouri">Albert S Khouri, MD</a>,&#160;<a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>&#160;by <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a> on August 15, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Tele-Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Tele-Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Benefits"><span class="tocnumber">1</span> <span class="toctext">Benefits</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#US_and_International_Initiatives"><span class="tocnumber">2</span> <span class="toctext">US and International Initiatives</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Tele-glaucoma_Modalities"><span class="tocnumber">3</span> <span class="toctext">Tele-glaucoma Modalities</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Remote_Testing"><span class="tocnumber">4</span> <span class="toctext">Remote Testing</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Challenges_and_Future_Directions"><span class="tocnumber">5</span> <span class="toctext">Challenges and Future Directions</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Benefits">Benefits</span></h1>
<p>Glaucoma is a progressive optic neuropathy with characteristic optic nerve structural damage and visual field loss. Glaucoma is one of the common causes of irreversible blindness worldwide.1<sup id="cite_ref-parihar1_1-0" class="reference"><a href="#cite_note-parihar1-1">&#91;1&#93;</a></sup> While there are many types of glaucoma including open-angle, closed-angle, and normal tension glaucoma; primary open-angle glaucoma is the most frequent encountered in the  US 2,3.<sup id="cite_ref-kassam2_2-0" class="reference"><a href="#cite_note-kassam2-2">&#91;2&#93;</a></sup><sup id="cite_ref-damji3_3-0" class="reference"><a href="#cite_note-damji3-3">&#91;3&#93;</a></sup> Primary open angle glaucoma is often labeled as the “silent thief of vision” due its characteristic painless and slow progression of mostly peripheral vision loss1. There are many barriers that prevent patients from seeking appropriate eye care including, but not limited to, geographic, educational, socioeconomic, and cultural considerations. 2,3<sup id="cite_ref-kassam2_2-1" class="reference"><a href="#cite_note-kassam2-2">&#91;2&#93;</a></sup><sup id="cite_ref-damji3_3-1" class="reference"><a href="#cite_note-damji3-3">&#91;3&#93;</a></sup>
</p><p>Tele-glaucoma helps overcome these barriers by relying on remote consultation or screening tools. Tele-glaucoma can be applied for screening or consultation. When applied for remote screening tele-glaucoma can  to detect glaucoma in order to initiate prompt treatment. When applied for remote consultation glaucoma patients can be followed remotely over time in order to monitor treatment over time. 
</p><p>Early action is pivotal in preventing glaucoma’s blinding complications. Glaucoma patients can particularly benefit from a tele-medicine approach because patients tend to be older and thus loss of vision can severely affect their mobility, and consequently, their quality of life. By delivering glaucoma care remotely, tele-glaucoma shows promise in providing patients with access to specialized ocular care. This can also be very useful for remote rural or underserved areas and has the potential to revolutionize the current healthcare paradigm of “first come, first serve.”2<sup id="cite_ref-kassam2_2-2" class="reference"><a href="#cite_note-kassam2-2">&#91;2&#93;</a></sup> Furthermore, current healthcare models do not distinguish between patients with progressive glaucoma who require timely intervention and health care access and those who do not need imminent care. Tele-glaucoma by identifying the most advanced or progressing patients may transform current clinical practice by prioritizing the delivery of care to patients who require the most urgent intervention. 2<sup id="cite_ref-kassam2_2-3" class="reference"><a href="#cite_note-kassam2-2">&#91;2&#93;</a></sup>
</p>
<h1><span class="mw-headline" id="US_and_International_Initiatives">US and International Initiatives</span></h1>
<p>Several tele-glaucoma clinical studies are ongoing in the US and internationally. 4<sup id="cite_ref-shahid4_4-0" class="reference"><a href="#cite_note-shahid4-4">&#91;4&#93;</a></sup> In the US, tele-glaucoma is making a significant impact on providing care to rural veterans as well as homeless veterans in a program piloted by the Atlanta VA clinic. This program is called Technology-based Eye Care Services (TECS).<sup id="cite_ref-rural5_5-0" class="reference"><a href="#cite_note-rural5-5">&#91;5&#93;</a></sup> On average, veterans are more vulnerable than the general population for eye diseases like glaucoma because enrollees are usually older patients and are thus less likely to see eye care professionals regularly.  TECS successfully illustrated that tele-glaucoma allowed veterans to seek timely access to eye care and significantly reduced the cost of eye exams for both the patient as well as the VA health care system. Other tele-glaucoma studies include trials in Philadelphia at Wills Eye Hospital and in Newark at Rutgers New Jersey Medical school. 
</p><p>Global efforts in tele-glaucoma are also being made, with many initiatives based in Africa due to a disproportionately high prevalence of glaucoma cases in African populations.<sup id="cite_ref-damji6_6-0" class="reference"><a href="#cite_note-damji6-6">&#91;6&#93;</a></sup><sup id="cite_ref-kiage7_7-0" class="reference"><a href="#cite_note-kiage7-7">&#91;7&#93;</a></sup> Given that the general awareness of glaucoma may be low, and the disease is mostly painless and harder to detect; many patients remain undiagnosed, and thus, untreated. Tele-glaucoma has the potential to bridge this gap by delivering care to those who would otherwise be unable to seek it.  
</p><p>Additionally, the American Academy of Ophthalmology has recognized the value of telemedicine and has sponsored a task force on tele-ophthalmology. For example, tele-ophthalmology has proven to successfully improve and extend ophthalmic care in diabetic retinopathy and retinopathy of prematurity. With advances in intraocular pressure monitoring and optic nerve analysis, the Academy's goal is to expand this successful initiative  to the realm of tele-glaucoma in order to improve the detection and treatment of glaucoma and have a positive impact on qualities of life and patient outcomes. <sup id="cite_ref-telemedicine8_8-0" class="reference"><a href="#cite_note-telemedicine8-8">&#91;8&#93;</a></sup>
</p><p><br />
</p>
<h1><span class="mw-headline" id="Tele-glaucoma_Modalities">Tele-glaucoma Modalities</span></h1>
<p>Tele-glaucoma is an integral part of tele-ophthalmology which aims to detect the leading vision threatening diseases (cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy).<sup id="cite_ref-telemedicine8_8-1" class="reference"><a href="#cite_note-telemedicine8-8">&#91;8&#93;</a></sup> Ophthalmic evaluation for visual acuity, non-contact tonometry, structure (including OCT), and function testing can be mobilized with a small footprint to allow travel to satellite or remote sites. There are 2 major modalities within tele-glaucoma: store and forward versus telepresence.
</p><p>Store and forward telemedicine refers to collecting relevant data from patients without real time live interaction with a physician. Store and forward tele-medicine is especially applicable to specialties such as ophthalmology because diagnoses are largely based on documented information and images. Images and test results are gathered into a single file at the screening site and then sent to the appropriate professionals via a secure encrypted Internet connection. Once received, the data are analyzed by a specialist as if the data was collected in person at the clinic. By not requiring specialists on site, the store and forward modality furthers the reach of tele-glaucoma in remote regions.<sup id="cite_ref-bonnardot10_9-0" class="reference"><a href="#cite_note-bonnardot10-9">&#91;9&#93;</a></sup><sup id="cite_ref-store11_10-0" class="reference"><a href="#cite_note-store11-10">&#91;10&#93;</a></sup>
</p><p>In contrast, the telepresence modality places a specialist directly in contact with the screening team. The same images and data are collected, but live consultations allow providers to disseminate immediate diagnoses, treatment suggestions, and expert referrals, as needed.  This “real time” tele-medicine modality is especially useful for clinicians who see many patients and for patients who need more immediate medical attention. 6,9<sup id="cite_ref-damji6_6-1" class="reference"><a href="#cite_note-damji6-6">&#91;6&#93;</a></sup><sup id="cite_ref-szirth9_11-0" class="reference"><a href="#cite_note-szirth9-11">&#91;11&#93;</a></sup> Telepresence also has the potential to circumvent the problem with patients failing to follow-up afterwards with an ophthalmologist after their screening encounter.
</p>
<h1><span class="mw-headline" id="Remote_Testing">Remote Testing</span></h1>
<p>During telemedicine for glaucoma, intraocular pressure measurement must avoid the use of topical anesthetics (requires presence of a supervising physician, nursing staff, and carries the potential risk of adverse effects). Current technologies are available that allow for remote IOP measurement. For example, non-contact tonometry, or "air puff" tonometry, can be used to noninvasively measure IOP. <sup id="cite_ref-raina12_12-0" class="reference"><a href="#cite_note-raina12-12">&#91;12&#93;</a></sup> Although puff tonometry correlates with application tonometry discrepancies may occur. Optical coherence tomography (OCT) is also a common imaging tool that can be brought to screening sites to assess glaucomatous structural damage. OCT is a noninvasive tool that allows screeners to acquire cross sectional images of the retina and optic nerve head (ONH) without dilating the pupil. Spectral domain (SD)-OCT can be used to diagnose thinning of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL), as well as ONH structural changes.<sup id="cite_ref-bussel13_13-0" class="reference"><a href="#cite_note-bussel13-13">&#91;13&#93;</a></sup> Thus, SD-OCT is a valuable clinical tool in diagnosing glaucoma and following its progression at screening sites. 
</p><p>Additionally, non-mydriatic digital color fundus photos are obtained as part of a complete ocular evaluation during screening or consultation. Incorporating software digital filters to process images has been shown to facilitate the identification of ocular pathology. This may assist screeners in identifying abnormalities on images during screening . <sup id="cite_ref-xia14_14-0" class="reference"><a href="#cite_note-xia14-14">&#91;14&#93;</a></sup><sup id="cite_ref-kolomeyer15_15-0" class="reference"><a href="#cite_note-kolomeyer15-15">&#91;15&#93;</a></sup> 
</p><p>New, wearable and portable brain-computer interface devices are making headway in detecting visual field changes from glaucoma. Some  cellphone-based technologies rely on head-mounted displays to detect electrical brain potential signals associated with visual field stimulation. This technology can successfully discriminate between healthy and glaucomatous eyes. The  portability and ease of use makes these technologies a promising asset for tele-glaucoma functional testing in the future.<sup id="cite_ref-nakanishi16_16-0" class="reference"><a href="#cite_note-nakanishi16-16">&#91;16&#93;</a></sup>
</p><p>Finally, the new and evolving field of robotics has applications during tele-glaucoma by allowing a remotely present physician virtual and physical presence with the screening team and the subjects being evaluated. Additionally, the field of artificial intelligence with deep learning algorithms continue to show an impressively high performance (aROC, sensitivity and specificity) in identifying ocular pathology (like diabetic retinopathy and glaucoma).<sup id="cite_ref-ting17_17-0" class="reference"><a href="#cite_note-ting17-17">&#91;17&#93;</a></sup> Hybrid deep learning methods  have also been used in conjunction with OCT to distinguish healthy eyes from eyes with early glaucoma.<sup id="cite_ref-muhammad18_18-0" class="reference"><a href="#cite_note-muhammad18-18">&#91;18&#93;</a></sup> With further improvement and wider adoption of these algorithms, artificial intelligence systems have the potential to change the face of tele-glaucoma, and ultimately, telemedicine as a whole.
</p>
<h1><span class="mw-headline" id="Challenges_and_Future_Directions">Challenges and Future Directions</span></h1>
<p>Patient retention and follow-up after glaucoma detection remains problematic. Many patients do not follow up as recommended. Furthermore, glaucoma patients are often elderly and face vision loss and mobility restrictions which can hinder traditional glaucoma care. Tele-glaucoma can offer solutions to the afore mentioned challenges. 
</p><p>Tele-glaucoma shows promise in delivering effective screening solutions, especially for remote and underserved communities. The regulatory and reimbursement policy challenges remain an obstacle to the wider implementation of tele-glaucoma. <sup id="cite_ref-thomas19_19-0" class="reference"><a href="#cite_note-thomas19-19">&#91;19&#93;</a></sup>
</p><p>Glaucoma affected 60.5 million people worldwide in 2010 and is projected to impact 79.6 million by 2020. Tele-glaucoma has the potential to remotely diagnose and plan treatment at the time of encounter. Tele-glaucoma has the potential to alleviate some of the obstacles to traditional glaucoma care, including the transportation of elderly visually disabled patients. Tele-glaucoma also has the ability to prioritize the delivery of care to the patients that need it more urgently- thus reducing risks of irreversible damage to vision in those patients.
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-parihar1-1"><span class="mw-cite-backlink"><a href="#cite_ref-parihar1_1-0">↑</a></span> <span class="reference-text">1 Parihar, J. K. S. Glaucoma: The ‘Black hole’ of irreversible blindness. Med. J. Armed Forces India 72, 3–4 (2016).</span>
</li>
<li id="cite_note-kassam2-2"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-kassam2_2-0">2.0</a></sup> <sup><a href="#cite_ref-kassam2_2-1">2.1</a></sup> <sup><a href="#cite_ref-kassam2_2-2">2.2</a></sup> <sup><a href="#cite_ref-kassam2_2-3">2.3</a></sup></span> <span class="reference-text">2 Kassam, F., Yogesan, K., Sogbesan, E., Pasquale, L. R. &amp; Damji, K. F. Teleglaucoma: Improving Access and Efficiency for Glaucoma Care. Middle East Afr. J. Ophthalmol. 20, 142–149 (2013).</span>
</li>
<li id="cite_note-damji3-3"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-damji3_3-0">3.0</a></sup> <sup><a href="#cite_ref-damji3_3-1">3.1</a></sup></span> <span class="reference-text">3 Damji, K. F. Strengthening Institutional Capacity for Glaucoma Care in Sub-Saharan Africa. Middle East Afr. J. Ophthalmol. 20, 107–110 (2013).</span>
</li>
<li id="cite_note-shahid4-4"><span class="mw-cite-backlink"><a href="#cite_ref-shahid4_4-0">↑</a></span> <span class="reference-text">4 Shahid, K. et al. Ocular Telehealth Screenings in an Urban Community. Telemed. E-Health 18, 95–100 (2012).</span>
</li>
<li id="cite_note-rural5-5"><span class="mw-cite-backlink"><a href="#cite_ref-rural5_5-0">↑</a></span> <span class="reference-text">Rural and Remote Health. Available at: <a rel="nofollow" class="external free" href="https://www.rrh.org.au/journal/article/4045">https://www.rrh.org.au/journal/article/4045</a> (Accessed: 27th June 2018)</span>
</li>
<li id="cite_note-damji6-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-damji6_6-0">6.0</a></sup> <sup><a href="#cite_ref-damji6_6-1">6.1</a></sup></span> <span class="reference-text">Damji, K. F. et al. STOP Glaucoma in Sub Saharan Africa: enhancing awareness, detection, management, and capacity for glaucoma care. Expert Rev. Ophthalmol. 12, 197–206 (2017).</span>
</li>
<li id="cite_note-kiage7-7"><span class="mw-cite-backlink"><a href="#cite_ref-kiage7_7-0">↑</a></span> <span class="reference-text">Kiage, D., Kherani, I. N., Gichuhi, S., Damji, K. F. &amp; Nyenze, M. The Muranga Teleophthalmology Study: Comparison of Virtual (Teleglaucoma) with in-Person Clinical Assessment to Diagnose Glaucoma. Middle East Afr. J. Ophthalmol. 20, 150–157 (2013).</span>
</li>
<li id="cite_note-telemedicine8-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-telemedicine8_8-0">8.0</a></sup> <sup><a href="#cite_ref-telemedicine8_8-1">8.1</a></sup></span> <span class="reference-text">Telemedicine for Ophthalmology Information Statement - 2018. American Academy of Ophthalmology (2018). Available at: <a rel="nofollow" class="external free" href="https://www.aao.org/clinical-statement/telemedicine-ophthalmology-information-statement">https://www.aao.org/clinical-statement/telemedicine-ophthalmology-information-statement</a>. (Accessed: 27th June 2018)</span>
</li>
<li id="cite_note-bonnardot10-9"><span class="mw-cite-backlink"><a href="#cite_ref-bonnardot10_9-0">↑</a></span> <span class="reference-text">Bonnardot, L. &amp; Rainis, R. Store-and-forward telemedicine for doctors working in remote areas, Store-and-forward telemedicine for doctors working in remote areas. J. Telemed. Telecare 15, 1–6 (2009).</span>
</li>
<li id="cite_note-store11-10"><span class="mw-cite-backlink"><a href="#cite_ref-store11_10-0">↑</a></span> <span class="reference-text">Store-and-forward teledermatology results in similar clinical outcomes to conventional clinic-based care, Store-and-forward teledermatology results in similar clinical outcomes to conventional clinic-based care. J. Telemed. Telecare 13, 26–30 (2007).</span>
</li>
<li id="cite_note-szirth9-11"><span class="mw-cite-backlink"><a href="#cite_ref-szirth9_11-0">↑</a></span> <span class="reference-text">Szirth, B., Khouri, A., Bhagat, N. &amp; Shahid, K. New Concepts in Screening for Vision Threatening Disease. Invest. Ophthalmol. Vis. Sci. 48, 1578–1578 (2007).</span>
</li>
<li id="cite_note-raina12-12"><span class="mw-cite-backlink"><a href="#cite_ref-raina12_12-0">↑</a></span> <span class="reference-text">Raina, U. K., Rathie, N., Gupta, A., Gupta, S. K. &amp; Thakar, M. Comparison of Goldmann applanation tonometer, Tono-Pen and noncontact tonometer in children. Oman J. Ophthalmol. 9, 22–26 (2016).</span>
</li>
<li id="cite_note-bussel13-13"><span class="mw-cite-backlink"><a href="#cite_ref-bussel13_13-0">↑</a></span> <span class="reference-text">Bussel, I. I., Wollstein, G. &amp; Schuman, J. S. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br. J. Ophthalmol. 98, ii15–ii19 (2014).</span>
</li>
<li id="cite_note-xia14-14"><span class="mw-cite-backlink"><a href="#cite_ref-xia14_14-0">↑</a></span> <span class="reference-text">Xia, T., Patel, S. N., Szirth, B. C., Kolomeyer, A. M. &amp; Khouri, A. S. Software-Assisted Depth Analysis of Optic Nerve Stereoscopic Images in Telemedicine. Int. J. Telemed. Appl. 2016, 7603507 (2016).</span>
</li>
<li id="cite_note-kolomeyer15-15"><span class="mw-cite-backlink"><a href="#cite_ref-kolomeyer15_15-0">↑</a></span> <span class="reference-text">Kolomeyer, A. M. et al. Software-Assisted Analysis During Ocular Health Screening. Telemed. E-Health 19, 2–6 (2013).</span>
</li>
<li id="cite_note-nakanishi16-16"><span class="mw-cite-backlink"><a href="#cite_ref-nakanishi16_16-0">↑</a></span> <span class="reference-text">Nakanishi, M. et al. Detecting Glaucoma With a Portable Brain-Computer Interface for Objective Assessment of Visual Function Loss. JAMA Ophthalmol. 135, 550–557 (2017).</span>
</li>
<li id="cite_note-ting17-17"><span class="mw-cite-backlink"><a href="#cite_ref-ting17_17-0">↑</a></span> <span class="reference-text">Ting, D. S. W. et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA 318, 2211–2223 (2017).</span>
</li>
<li id="cite_note-muhammad18-18"><span class="mw-cite-backlink"><a href="#cite_ref-muhammad18_18-0">↑</a></span> <span class="reference-text">Muhammad, H. et al. Hybrid Deep Learning on Single Wide-field Optical Coherence tomography Scans Accurately Classifies Glaucoma Suspects. J. Glaucoma 26, 1086–1094 (2017).</span>
</li>
<li id="cite_note-thomas19-19"><span class="mw-cite-backlink"><a href="#cite_ref-thomas19_19-0">↑</a></span> <span class="reference-text">Thomas, S.-M. et al. The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis. PLOS ONE 9, e113779 (2014).</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035201
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.140 seconds
Real time usage: 1.234 seconds
Preprocessor visited node count: 612/1000000
Post‐expand include size: 4991/2097152 bytes
Template argument size: 1105/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 9557/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  668.603      1 Template:Article
100.00%  668.603      1 -total
 80.23%  536.393      4 Template:Infobox_section
 21.32%  142.547      5 Template:UserLookup
  8.15%   54.515      1 Template:Infobox_begin
  6.81%   45.538      1 Template:Review_expired
  3.34%   22.333      1 Template:Infobox_end
  0.25%    1.683      1 Template:Get_active_contest
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Tele-Glaucoma&amp;oldid=83950">https://eyewiki.org/w/index.php?title=Tele-Glaucoma&amp;oldid=83950</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzz03ga7">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Tele-Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Tele-Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Tele-Glaucoma&amp;oldid=83950" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Tele-Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on August 15, 2022, at 09:17.</div>
					<div>This page has been accessed 9,822 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.140","walltime":"1.234","ppvisitednodes":{"value":612,"limit":1000000},"postexpandincludesize":{"value":4991,"limit":2097152},"templateargumentsize":{"value":1105,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":9557,"limit":5000000},"timingprofile":["100.00%  668.603      1 Template:Article","100.00%  668.603      1 -total"," 80.23%  536.393      4 Template:Infobox_section"," 21.32%  142.547      5 Template:UserLookup","  8.15%   54.515      1 Template:Infobox_begin","  6.81%   45.538      1 Template:Review_expired","  3.34%   22.333      1 Template:Infobox_end","  0.25%    1.683      1 Template:Get_active_contest"]},"cachereport":{"timestamp":"20230306035201","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":2992});});</script></body>
</html>